ArTS Archivio della ricerca di Trieste

MUSTACCHI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.935
NA - Nord America 5.412
AS - Asia 2.455
SA - Sud America 254
AF - Africa 125
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 7
Totale 31.209
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.201
US - Stati Uniti d'America 5.356
SG - Singapore 981
CN - Cina 506
FR - Francia 466
UA - Ucraina 396
SE - Svezia 324
GB - Regno Unito 242
VN - Vietnam 235
HK - Hong Kong 232
DE - Germania 223
NL - Olanda 210
BR - Brasile 189
KR - Corea 162
CH - Svizzera 155
FI - Finlandia 139
PL - Polonia 125
RU - Federazione Russa 102
TR - Turchia 76
MA - Marocco 70
IE - Irlanda 66
IN - India 64
BG - Bulgaria 63
BD - Bangladesh 42
RO - Romania 41
ES - Italia 34
AL - Albania 29
CA - Canada 29
AR - Argentina 24
BE - Belgio 24
JP - Giappone 21
EU - Europa 20
IQ - Iraq 19
CI - Costa d'Avorio 17
IR - Iran 16
GR - Grecia 14
PT - Portogallo 14
MX - Messico 13
MY - Malesia 13
DK - Danimarca 12
AT - Austria 11
JO - Giordania 11
PK - Pakistan 11
SA - Arabia Saudita 10
ZA - Sudafrica 10
CL - Cile 9
CZ - Repubblica Ceca 9
IL - Israele 9
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
KE - Kenya 7
AE - Emirati Arabi Uniti 6
SI - Slovenia 6
SM - San Marino 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
HR - Croazia 5
PY - Paraguay 5
TH - Thailandia 5
TN - Tunisia 5
JM - Giamaica 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PH - Filippine 4
DZ - Algeria 3
EG - Egitto 3
HU - Ungheria 3
MD - Moldavia 3
OM - Oman 3
AO - Angola 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CF - Repubblica Centrafricana 1
CG - Congo 1
CM - Camerun 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
LB - Libano 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
Totale 31.202
Salva come PNG Salva come JPEG
Città #
Rome 1.159
Milan 1.107
Singapore 595
Woodbridge 538
Ann Arbor 424
Ashburn 408
Fairfield 379
Jacksonville 340
Houston 333
Naples 323
Chandler 320
San Jose 281
Hong Kong 228
Florence 227
Wilmington 218
Turin 204
Bologna 201
Seattle 185
Hefei 176
Seoul 161
Trieste 160
Padova 158
Palermo 157
Napoli 138
Cambridge 132
Princeton 118
Bari 114
Boardman 113
Torino 109
Genoa 100
Catania 96
Dallas 96
Brescia 91
Santa Clara 91
Ho Chi Minh City 83
Beijing 80
Chicago 77
Cagliari 76
Verona 72
Perugia 63
Casablanca 62
Columbus 61
Dublin 61
Bergamo 60
Sofia 59
Zgierz 59
Izmir 57
Lauterbourg 54
Hanoi 46
Buffalo 45
Pescara 45
Monza 44
Moscow 44
Caserta 43
Messina 42
Genova 41
Mountain View 41
Udine 41
Amsterdam 40
Como 40
Dearborn 37
Treviso 37
Venezia 37
Reggio Calabria 36
Los Angeles 35
Vicenza 34
Pisa 33
Modena 32
Sassari 32
Lucca 31
London 30
San Diego 30
The Dalles 30
Ancona 29
Taranto 29
Venice 29
Latina 28
New York 28
Catanzaro 27
Frankfurt am Main 27
Prato 27
Reggio Nell'emilia 26
Parma 25
Livorno 24
Helsinki 23
Pavia 23
Salerno 23
Bremen 22
Foggia 22
Redwood City 22
Siena 22
Novara 21
São Paulo 21
Trento 21
Mumbai 20
Düsseldorf 19
Ferrara 19
Abbiategrasso 18
Legnano 18
Mestre 18
Totale 11.981
Salva come PNG Salva come JPEG
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.839
Advances in systemic therapy for metastatic breast cancer: future perspectives 421
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach. 284
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 257
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 245
Breast cancer in elderly women: a different reality? Results from the NORA Study 225
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 219
Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial 217
Adjuvant systemic treatment of early breast cancer: The NORA study. 215
Role of lifestyles in breast cancer risk: a retrospective analysis of Trieste's female population 212
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. 203
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. 201
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. 196
Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials 191
Early detection of breast cancer recurrences through periodic follow up - Is it useless? 190
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study. 186
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 184
Psychological Response to Cancer: Role of 5-HTTLPR Genetic Polymorphism of Serotonin Transporter 181
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 173
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer 173
Gene expression profiling in breast cancer: A clinical perspective 170
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database 168
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancerdeath: meta-analysis of individual patient data for 10,801 women in 17 randomised trials 166
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 7 years of the 1st GROCTA Trial. 165
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study 163
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy. 160
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs 159
A multicentre, double blind, randomised trial comparing ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 158
Cancro del fegato: possibilità di diagnosi precoce 158
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study 157
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study. 155
Changes in adjuvant treatment of early breast cancer in Italy between 2000 and 2008. The NEMESI study versus the NORA study. 155
Carcinoma dell’ovaio 151
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. 149
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study. 148
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 146
ITALIAN BREAST CANCER ADJUVANT CHEMO-HORMONE THERAPY COOPERATIVE GROUP TRIALS 145
Effectiveness of magnetotheraphy in resolution of some early complications of the mastectomy operation. 143
Gli antidoti in Oncologia medica: efficacia, costo e beneficio 141
Chemotherapy vs Tamoxifen vs Chemotherapy + Tamoxifen in Node-positive, Oestrogen-receptor positive Breast Cancer Patients. An update at 8 years of the first GROCTA (Italian Cooperative Group for Adjuvant Chemo-Hormonal Therapy of Breast cancer)Trial. 137
Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting. J Clin Oncol 30, 2012 (suppl; abstr 586) 134
La metanalisi di Oxford del 2000: riflessioni e commenti 133
Modulating effect of Lonidamine on Response to Doxorubicin in Metastatic Breast cancer patients: Results from a Multicenter Prospective Randomized Trial. 131
Molecular targets of cancer chemotherapy 131
The combination of Metoclopramide, Methylprednisolone and Ondansetron against antiblastic - delayed emesis: a randomised Phase II study. 130
Un programme de réhabilitation chez la femme mastectomisée 128
Ovarian function in premenopausal women affected by breast cancer: the measurement of glucuronoconjugate metabolites of 17-beta-estradiol and progesterone throughout one entire menstrual cycle 126
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group 126
Extragonadal Germ Cell Tumor: a Clinical Stdy. 122
Il Carcinoma del Fegato: Realtà e Prospettive Epidemiologia 116
La communication du diagnostic de cancer 113
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 112
Observer variations in mammary thermography: results of a teaching file test carried out in four different centers 112
Tamoxifen or Surgery plus Tamoxifen as primary treatment for elderly patients with operable breast cancer: the G.R.E.T.A. Trial 109
Prolonged Tamoxifen Treatment of Early Breast Cancer: The experience of the Italian Cooperative Group for Chemo-Hormonal Therapy of Early Breast Cancer. 106
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial. 99
Effect of menstrual status on response to adjuvant chemotherapy and /or endocrine therapy. 98
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials. 98
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study 96
Role of erythropoietin in the oncology patient: critical review of the literature 95
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 83
Totale 31.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.895 112 142 124 154 121 95 101 110 211 171 169 385
2022/20234.469 323 320 351 347 367 472 293 369 427 284 451 465
2023/20243.525 447 401 315 332 273 185 351 326 76 289 283 247
2024/20252.813 274 286 485 246 235 208 167 153 304 171 156 128
2025/20263.209 255 248 242 315 239 313 367 140 385 488 121 96
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 31.504